Outcomes of severe aspergillosis in patients undergoing extracorporeal membrane oxygenation: A systematic review
- PMID: 39310994
- DOI: 10.1111/aor.14871
Outcomes of severe aspergillosis in patients undergoing extracorporeal membrane oxygenation: A systematic review
Abstract
Background: Invasive aspergillosis (IA) can lead to life-threatening respiratory failure necessitating extracorporeal membrane oxygenation (ECMO) support. However, data on ECMO experience in the management of IA patients are scarce.
Objectives: The purpose of this systematic review was to evaluate the potential benefits and risks of ECMO as a supportive intervention for critically ill patients with IA.
Methods: We conducted a systematic review of the literature using the search terms ECMO, extracorporeal membrane oxygenation, Aspergillus and Aspergillosis in two databases (Medline and Scopus). Clinical data were extracted by two independent investigators. Clinical parameters, such as mode of ECMO support, duration of treatment and clinical outcomes, were assessed.
Results: Overall, 32 patients were included in the analysis. The age ranged from 5 to 69 years, 59% were male, and 38% were female. The majority of patients suffered from ARDS (82%). 82% received VV-ECMO, and 18% received VA-ECMO. Aspergillus fumigatus was the most frequent cause of IA, coinfections were frequently observed (51%). The overall mortality was 78%. Complications during ECMO support were observed in 21 of the 39 cases (53.8%).
Conclusions: IA poses significant management challenges for critically ill ICU patients, even with ECMO support. Although ECMO appears to improve survival of patients at high risk of AI, potential risks such as bacterial superinfection and altered pharmacokinetics of antifungal drugs must be carefully considered.
Keywords: Aspergillus; ECMO; extracorporeal support; fungi; invasive aspergillosis; mycosis.
© 2024 International Center for Artificial Organ and Transplantation (ICAOT) and Wiley Periodicals LLC.
References
REFERENCES
-
- Baddley JW, Stephens JM, Ji X, Gao X, Schlamm HT, Tarallo M. Aspergillosis in intensive care unit (ICU) patients: epidemiology and economic outcomes. BMC Infect Dis. 2013;13:29.
-
- Segal BH. Aspergillosis. N Engl J Med. 2009;360(18):1870–1884.
-
- Kluge S, Strauß R, Kochanek M, Weigand MA, Rohde H, Lahmer T. Aspergillosis: emerging risk groups in critically ill patients. Med Mycol. 2021;60(1):myab064.
-
- Azoulay E, Russell L, Van de Louw A, Metaxa V, Bauer P, Povoa P, et al. Diagnosis of severe respiratory infections in immunocompromised patients. Intensive Care Med. 2020;46(2):298–314.
-
- Bassetti M, Peghin M, Vena A. Challenges and solution of invasive aspergillosis in non‐neutropenic patients: a review. Infect Dis Ther. 2018;7(1):17–27.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
